Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine - a meta-analysis
Unknown authors
Published in BMJ Open
Key Findings
CoQ10 reduced migraine attack frequency versus control (MD -1.52 attacks, 95% CI -2.40 to -0.65) with no heterogeneity.
Conclusions
Pooled RCT data support CoQ10 for migraine prophylaxis, consistent with a mitochondrial bioenergetic mechanism.
Supplements Studied
CoQ10 usage reduced the frequency of migraine headache compared with the control group.
Outcomes Measured
CoQ10 usage reduced the frequency of migraine headache compared with the control group (MD: -1.52; 95% CI: -2.40 to -0.65).
CoQ10 reduced migraine attack frequency versus control (MD -1.52 attacks, 95% CI -2.40 to -0.65) with no heterogeneity.
CoQ10 appears to have beneficial effects in reducing duration and frequency of migraine attack.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.